معرفی
Prof. Matthias Merkenschlager is a Professor of Cell Biology at Imperial College London's Faculty of Medicine, leading the Lymphocyte Development Research Group at the MRC London Institute of Medical Sciences (MRC LMS). He has held academic roles since 1993, including Programme Leader at MRC LMS and Reader at Imperial College. His research focuses on gene regulatory mechanisms in cell type specification, particularly involving transcription factors, epigenetic states, and 3D genome organization. Key achievements include EMBO membership and Fellowship of the Academy of Medical Sciences.
Education:
- MD (1977–1984): Free University of Berlin and Technical University Munich
- PhD (1983–1985): University College London
Research Interests: His work addresses how cell fate decisions are influenced by transcriptional and epigenetic networks, with emphasis on lymphocyte development. Specific topics include cohesin's role in genome organization, X-chromosome-linked genetic diversity, and the interplay between chromatin architecture and gene expression. These studies bridge basic science and clinical applications, such as understanding disease susceptibility and developing therapies for cohesinopathies.
Key Contributions:
- Discovered cohesin's role in T-cell receptor rearrangement and thymocyte differentiation.
- Pioneered methods linking chromatin conformation to gene regulation using advanced computational tools.
- Investigated transgenerational epigenetic effects of prenatal dietary interventions.
Awards:
- Fellow of the Academy of Medical Sciences (2009)
- Member of EMBO (2013)
Lab & Collaborations: The Lymphocyte Development Group collaborates widely, integrating experimental and computational approaches. Current projects explore how 3D genome architecture enables adaptive responses to environmental signals, with implications for immunology and developmental disorders.
